Jennison Associates
ADPT icon

Jennison Associates’s Adaptive Biotechnologies ADPT Stock Holding History

Jennison Associates’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
686,195
-66,878
-9% -$1.02M 0.01% 365
2026
Q1 		$10.5M Sell
753,073
-1,921,595
-72% -$30.6M 0.01% 383
2025
Q4 		$43.4M Buy
2,674,668
+1,363,181
+104% +$22.2M 0.03% 233
2025
Q3 		$19.6M Buy
1,311,487
+1,215,715
+1,269% +$14.8M 0.01% 331
2025
Q2 		$1.12M Buy
95,772
+403
+0.4% +$3.66K ﹤0.01% 474
2025
Q1 		$709K Sell
95,369
-82,489
-46% -$634K ﹤0.01% 512
2024
Q4 		$1.07M Sell
177,858
-53,673
-23% -$296K ﹤0.01% 486
2024
Q3 		$1.19M Buy
231,531
+53,908
+30% +$235K ﹤0.01% 473
2024
Q2 		$643K Buy
177,623
+2,856
+2% +$9.06K ﹤0.01% 529
2024
Q1 		$561K Buy
174,767
+31,547
+22% +$122K ﹤0.01% 553
2023
Q4 		$702K Buy
143,220
+8,595
+6% +$39.2K ﹤0.01% 530
2023
Q3 		$734K Sell
134,625
-21,167
-14% -$140K ﹤0.01% 500
2023
Q2 		$1.05M Buy
155,792
+3,378
+2% +$25.1K ﹤0.01% 478
2023
Q1 		$1.35M Sell
152,414
-42,622
-22% -$376K ﹤0.01% 473
2022
Q4 		$1.49M Buy
195,036
+20,745
+12% +$161K ﹤0.01% 455
2022
Q3 		$1.24M Buy
+174,291
New +$1.64M ﹤0.01% 487
2019
Q3 		– Sell
-285,744
Closed -$13.8M – 637
2019
Q2 		$13.8M Buy
+285,744
New +$12.7M 0.01% 407

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jennison Associates's ADPT Position: Q2 2026 in Review

Jennison Associates reduced its Adaptive Biotechnologies (ADPT) stake by 8.9% in Q2 2026, selling an estimated $1.02M and leaving 686,195 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #365.

Jennison Associates first reported a position in ADPT in Q2 2019 and has held it in 17 quarters since. The position peaked at $43.4M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Jennison Associates held 686,195 shares of Adaptive Biotechnologies worth $14.7M as of Q2 2026.
  • Jennison Associates sold 66,878 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.02M.
  • Adaptive Biotechnologies made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #365 holding.
  • Jennison Associates first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 17 quarters since.
  • Jennison Associates's Adaptive Biotechnologies position peaked at $43.4M in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.